| Bid Price | 1.30p | High Price | 1.40p |
|---|
| Ask Price | 1.40p | Low Price | 1.30p |
|---|
| Open Price | 1.45p | Spread | 7.14% |
|---|
| Prev Close | 1.45p | Volume | 920,775 |
|---|
Roquefort Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 4, 2025 | 1.40 | 1.50 | 1.40 | 1.45 | 1,598,639 |
| Dec 3, 2025 | 1.43 | 1.50 | 1.30 | 1.40 | 1,355,408 |
| Dec 2, 2025 | 1.65 | 1.60 | 1.40 | 1.50 | 1,440,244 |
| Dec 1, 2025 | 1.65 | 1.90 | 1.60 | 1.70 | 4,707,586 |
| Nov 28, 2025 | 2.75 | 3.00 | 2.00 | 2.05 | 15,619,133 |
Roquefort Therapeutics PLC Information
| Name | Roquefort Therapeutics PLC | Index | |
|---|
| ISIN | GB00BMDQ2T15 | Epic | ROQ |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 50,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 157.44 m | Prev Close | 1.45p |
|---|
| PE Ratio | | Market Cap | £2.11 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.09011 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.802919 | Quick Ratio | 0.341394 |
|---|
Roquefort Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 24/11/25 | BUY | Darrin Disley | NED | 5,000,000 @ £0.02 | £85,000.00 |
| 07/07/25 | BUY | Stephen West | CH | 2,400,000 @ £0.02 | £36,000.00 |
| 30/06/25 | BUY | Simon Sinclair | NED | 72,507 @ £0.01 | £993.00 |
| 04/02/25 | BUY | Stephen West | CH | 400,000 @ £0.03 | £10,280.00 |
| 04/02/25 | BUY | Trevor Reginald | RES | 191,059 @ £0.03 | £4,968.00 |
| 04/12/24 | TIN | Darrin Disley | NED | 9,146 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Martin Evans | RES | 2,690 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Trevor Reginald | RES | 34,432 @ £0.00 | £0.00 |
| 02/08/23 | BUY | Darrin Disley | NED | 269,935 @ £0.07 | £19,840.00 |
| 12/07/23 | BUY | Stephen West | CH | 15,730 @ £0.06 | £983.00 |
Roquefort Therapeutics PLC News
